Current Research Interests
Emily earned a MS degree in Biostatistics from the University of Minnesota. There, her master’s thesis focused on developing an adaptive approach to dose-finding in Phase I cancer clinical trials that rapidly approaches the maximum tolerated dose while incorporating important patient characteristics or prognostic factors and controlling the probability of overdose.
Since coming to MSKCC, Emily’s primary collaboration has been with Dr. Helena Furberg in the area of nicotine dependence and smoking cessation. Their work has focused on the impact of smoking intensity and duration on prognosis in urologic cancers. In addition, they are investigating factors associated with use of cigarettes and Swedish smokeless oral tobacco (snus) among a large cohort of Swedish twins. Emily has also collaborated with Dr. Chaya Moskowitz on a variety of projects with the Radiology service, with a focus on evaluating the inter- and intra-rater reliability of tumor measurements from MRI or CT scan and determining the sensitivity and specificity of diagnostic imaging in numerous cancers. Finally, Emily collaborates with Dr. Colin Begg in developing methods to assess etiologic heterogeneity of cancer sub-types.
